Steris (STE): Director exercised options on 3,098 shares
Cynthia L Feldmann, Director at Steris, reported an option exercise of 3,098 shares.
- 3,098
- Shares · @ $152.32
- Traded
- Mar 5, 2026
- Filed
- Mar 6, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 4, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 6, 2026CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- Feb 10, 2026CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- Mar 5, 2026InsiderDirector sold ~$735K of STE shares in the open market
What came next
- Mar 16, 2026CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 31, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 31, 2026, STERIS plc (the “Company”) and Michael J. Tokich, the Company’s former Chief Financial Officer, entered into an amendment (the “Amendment”) to the Transition Agreement, dated August 5, 2025, between the Company and Mr. Tokich (the “Agreement”).”
- Apr 8, 2026FDAFDA device clearance: SYSTEM 1E Liquid Chemical Sterilant Processing System, Model P6700; SYSTEM 1 endo Liquid Chemical Sterilant Processing System, Model P6900
- Apr 8, 2026FDAFDA device clearance: Celerity 5 HP Biological Indicator (LCB052)
- Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.0%
- Apr 29, 2026CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- Apr 30, 2026CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- May 1, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On May 1, 2026, Richard C. Breeden notified STERIS plc (the “Company”) that he will not stand for reelection to the Board of Directors (the “Board”) at the Company’s 2026 Annual General Meeting of Shareholders.”
- May 1, 2026CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- May 11, 2026Company filing · Form 8-K · ResultsReported its results
- May 11, 2026Congress · 1 personMembers of Congress: 2 purchases
- May 12, 20265% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 5.1%
- May 13, 2026CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- May 15, 2026FDARecall: HarmonyAIR A-Series Surgical Lighting System
- May 15, 2026FDARecall: HarmonyAIR A-Series Surgical Lighting System
- May 15, 2026FDARecall: ALYON Surgical Lighting System
- Jun 2, 2026InsiderDirector sold ~$310K of STE shares in the open market
- Jun 4, 2026InsiderCEO sold ~$656K of STE shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Steris
For Steris, OQRO holds 7 insider filings (SEC Form 4 or Form 144) and 3 Congress trade reports dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its STE page.
Other recent filings by Cynthia L Feldmann, Director
- SEC Form 4 at Steris (STE)Mar 6, 2026
- SEC Form 4 at Steris (STE)Aug 12, 2025
- SEC Form 4 at UFP Technologies, Inc. (UFPT)Mar 5, 2025
- SEC Form 4 at UFP Technologies, Inc. (UFPT)Mar 5, 2025
- SEC Form 4 at UFP Technologies, Inc. (UFPT)Nov 8, 2024
The full history of Cynthia L Feldmann, Director is on the profile page.
How this filing works
Explore the data
Common questions
Which Steris (STE) insider traded, and how much?
Cynthia L Feldmann, Director at Steris, reported an option exercise of 3,098 shares. At $152.32.
When did it happen, and when was it made public?
Traded: Mar 5, 2026. Filed: Mar 6, 2026. That is 1 day between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Steris recently?
For Steris, OQRO holds 7 insider filings (SEC Form 4 or Form 144) and 3 Congress trade reports dated in the last 90 days. They are listed on the STE page.
Does this mean STE stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Steris
- SEC Form 4Nov 17, 2026
- SEC Form 144Nov 13, 2026
- SEC Form 144Nov 12, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 4Nov 12, 2026
Everything OQRO holds on this company is on its STE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
